| scholarly article | Q13442814 |
| P50 | author | Salvador Aznar Benitah | Q39033088 |
| Juan Carlos Lacal | Q40430195 | ||
| P2093 | author name string | Rosario Perona | |
| Isabel Sánchez-Pérez | |||
| Montserrat Martínez-Gomariz | |||
| P2860 | cites work | Mechanism of NF-kappa B translocation in macrophages treated in vitro with cisplatin | Q77157629 |
| Lack of c-Jun activity increases survival to cisplatin | Q77993726 | ||
| Cell stress and MKK6b-mediated p38 MAP kinase activation inhibit tumor necrosis factor-induced IkappaB phosphorylation and NF-kappaB activation | Q78069508 | ||
| Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation | Q93607580 | ||
| JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain | Q24308838 | ||
| Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms | Q24312029 | ||
| The NF-kappa B and I kappa B proteins: new discoveries and insights | Q24313579 | ||
| Identification of a dual specificity kinase that activates the Jun kinases and p38-Mpk2 | Q24313872 | ||
| The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression | Q24548310 | ||
| NF-kappaB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis | Q24554454 | ||
| Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli | Q24568220 | ||
| CREB-binding protein/p300 are transcriptional coactivators of p65 | Q24569596 | ||
| Interleukin-6 induction by tumor necrosis factor and interleukin-1 in human fibroblasts involves activation of a nuclear factor binding to a kappa B-like sequence | Q24598724 | ||
| Mapping of the inducible IkappaB phosphorylation sites that signal its ubiquitination and degradation | Q24650561 | ||
| MEKK1 activates both IkappaB kinase alpha and IkappaB kinase beta | Q24681806 | ||
| NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses | Q27861101 | ||
| A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD | Q28258328 | ||
| Interaction between c-Rel and the mitogen-activated protein kinase kinase kinase 1 signaling cascade in mediating kappaB enhancer activation | Q28277712 | ||
| MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1 | Q28302936 | ||
| Requirement for p38alpha in erythropoietin expression: a role for stress kinases in erythropoiesis | Q28505039 | ||
| Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300 | Q28619230 | ||
| Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B | Q28645847 | ||
| Activation of interleukin-6 gene expression through the NF-kappa B transcription factor | Q28646310 | ||
| Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis | Q29547567 | ||
| NF-kappaB in cancer: from innocent bystander to major culprit | Q29614603 | ||
| Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation | Q29614709 | ||
| The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta | Q29617188 | ||
| The stress-activated protein kinase subfamily of c-Jun kinases | Q29620001 | ||
| Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain | Q29620169 | ||
| Interaction of phosphatidylinositol 3-kinase-associated p85 with epidermal growth factor and platelet-derived growth factor receptors | Q31169174 | ||
| Loss of IkappaB alpha-mediated control over nuclear import and DNA binding enables oncogenic activation of c-Rel | Q33778864 | ||
| Control of apoptosis by Rel/NF-kappaB transcription factors | Q33797163 | ||
| Protein phosphatases and the regulation of mitogen-activated protein kinase signalling. | Q33860531 | ||
| Simultaneous tyrosine and serine phosphorylation of STAT3 transcription factor is involved in Rho A GTPase oncogenic transformation | Q33948297 | ||
| The Rel/NF-kappaB family directly activates expression of the apoptosis inhibitor Bcl-x(L). | Q33962748 | ||
| Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. | Q34131747 | ||
| I kappa B-independent control of NF-kappa B activity by modulatory phosphorylations | Q34179362 | ||
| MEK kinase 1 gene disruption alters cell migration and c-Jun NH2-terminal kinase regulation but does not cause a measurable defect in NF-kappa B activation | Q35156450 | ||
| N- and C-terminal sequences control degradation of MAD3/I kappa B alpha in response to inducers of NF-kappa B activity | Q36555088 | ||
| c-Jun N-terminal phosphorylation correlates with activation of the JNK subgroup but not the ERK subgroup of mitogen-activated protein kinases | Q36667357 | ||
| MEK kinase 1 is critically required for c-Jun N-terminal kinase activation by proinflammatory stimuli and growth factor-induced cell migration. | Q36967719 | ||
| Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-kappaB. | Q39451375 | ||
| CBP/p300 and muscle differentiation: no HAT, no muscle | Q39646212 | ||
| Mechanistic aspects of NF-kappa B regulation: the emerging role of phosphorylation and proteolysis | Q40410066 | ||
| Regulation of the DNA binding activity of NF-kappa B. | Q40429561 | ||
| Induction of gadd45beta by NF-kappaB downregulates pro-apoptotic JNK signalling. | Q40767950 | ||
| Fos is an essential component of the mammalian UV response | Q40789823 | ||
| Cisplatin inhibits the expression of X-chromosome-linked inhibitor of apoptosis protein in an oral carcinoma cell line | Q40815035 | ||
| Stimulation of p300-mediated transcription by the kinase MEKK1. | Q40817286 | ||
| The mammalian UV response: c-Jun induction is required for exit from p53-imposed growth arrest | Q40834838 | ||
| PI3-K/AKT regulation of NF-kappaB signaling events in suppression of TNF-induced apoptosis | Q40881979 | ||
| Cisplatin-induced apoptosis in human proximal tubular epithelial cells is associated with the activation of the Fas/Fas ligand system | Q40942580 | ||
| Role of IKK1 and IKK2 in lipopolysaccharide signaling in human monocytic cells | Q40996842 | ||
| The c-Jun N-terminal kinase cascade plays a role in stress-induced apoptosis in Jurkat cells by up-regulating Fas ligand expression. | Q41049409 | ||
| Cisplatin induces a persistent activation of JNK that is related to cell death | Q41062943 | ||
| Persistent activation of c-Jun N-terminal kinase 1 (JNK1) in gamma radiation-induced apoptosis | Q41239719 | ||
| Induction of apoptosis by the transcription factor c-Jun | Q42614297 | ||
| Activation of the nuclear factor-kappaB by Rho, CDC42, and Rac-1 proteins | Q42803708 | ||
| HER-2/neu blocks tumor necrosis factor-induced apoptosis via the Akt/NF-kappaB pathway | Q42804558 | ||
| Akt stimulates the transactivation potential of the RelA/p65 Subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen-activated protein kinase p38. | Q42830960 | ||
| Upregulation of Bcl-x and Bfl-1 as a potential mechanism of chemoresistance, which can be overcome by NF-kappaB inhibition | Q43614760 | ||
| Inhibition of JNK activation through NF-kappaB target genes | Q43802523 | ||
| NF-kappa B activation by ultraviolet light not dependent on a nuclear signal. | Q45971622 | ||
| DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kappa B and AP-1. | Q46784718 | ||
| c-Jun is essential for normal mouse development and hepatogenesis | Q57083732 | ||
| Stimulation of c-Jun activity by CBP: c-Jun residues Ser63/73 are required for CBP induced stimulation in vivo and CBP binding in vitro | Q57888777 | ||
| Functional Interplay Between Nuclear Factor-κB and c-Jun Integrated by Coactivator p300 Determines the Survival of Nerve Growth Factor-Dependent PC12 Cells | Q58661830 | ||
| Human ovarian cancer and cisplatin resistance: possible role of inhibitor of apoptosis proteins | Q64380181 | ||
| The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and gamma radiation. Duration of JNK activation may determine cell death and proliferation | Q71833616 | ||
| A c-Jun dominant negative mutant protects sympathetic neurons against programmed cell death | Q72232625 | ||
| Transactivation domain 2 (TA2) of p65 NF-kappa B. Similarity to TA1 and phorbol ester-stimulated activity and phosphorylation in intact cells | Q72350511 | ||
| The p38 mitogen-activated protein kinase is required for NF-kappaB-dependent gene expression. The role of TATA-binding protein (TBP) | Q73083269 | ||
| CL100/MKP-1 modulates JNK activation and apoptosis in response to cisplatin | Q73155209 | ||
| NF-kappa B activation results in rapid inactivation of JNK in TNF alpha-treated Ewing sarcoma cells: a mechanism for the anti-apoptotic effect of NF-kappa B | Q74244990 | ||
| Multiple signalling pathways lead to the activation of the nuclear factor kappaB by the Rho family of GTPases | Q74531638 | ||
| P433 | issue | 8 | |
| P304 | page(s) | 2933-2945 | |
| P577 | publication date | 2002-08-01 | |
| P1433 | published in | Molecular Biology of the Cell | Q2338259 |
| P1476 | title | Cell stress and MEKK1-mediated c-Jun activation modulate NFkappaB activity and cell viability | |
| P478 | volume | 13 |
| Q28547392 | A Central Role for JNK/AP-1 Pathway in the Pro-Oxidant Effect of Pyrrolidine Dithiocarbamate through Superoxide Dismutase 1 Gene Repression and Reactive Oxygen Species Generation in Hematopoietic Human Cancer Cell Line U937 |
| Q47942760 | Activation of TWIST1 by COL11A1 promotes chemoresistance and inhibits apoptosis in ovarian cancer cells by modulating NF-κB-mediated IKKβ expression. |
| Q42022163 | Activation of nuclear factor-kappaB in human prostate carcinogenesis and association to biochemical relapse |
| Q38899892 | Alpha-Tomatine Exhibits Anti-inflammatory Activity in Lipopolysaccharide-Activated Macrophages |
| Q37580192 | Androgen receptor activity modulates responses to cisplatin treatment in bladder cancer |
| Q35100882 | Anti-inflammatory effect of buddlejasaponin IV through the inhibition of iNOS and COX-2 expression in RAW 264.7 macrophages via the NF-kappaB inactivation |
| Q39870887 | Bis-(3-hydroxyphenyl) diselenide inhibits LPS-stimulated iNOS and COX-2 expression in RAW 264.7 macrophage cells through the NF-kappaB inactivation |
| Q64915016 | CUEDC2 Contributes to Cisplatin-Based Chemotherapy Resistance in Ovarian Serious Carcinoma by Regulating p38 MAPK Signaling. |
| Q36621547 | Cassia tora L. (Jue-ming-zi) has anticancer activity in TCA8113 cells in vitro and exerts anti-metastatic effects in vivo |
| Q37729428 | Common Chemical Inductors of Replication Stress: Focus on Cell-Based Studies |
| Q35647850 | Control of oncogenesis and cancer therapy resistance |
| Q59330226 | Cyclophilin A as a target in the treatment of cytomegalovirus infections |
| Q34347854 | D. candidum has in vitro anticancer effects in HCT-116 cancer cells and exerts in vivo anti-metastatic effects in mice |
| Q33962641 | Dendrobium candidum Wall. ex Lindl. attenuates CCl4-induced hepatic damage in imprinting control region mice |
| Q39034883 | Different affinity of nuclear factor-kappa B proteins to DNA modified by antitumor cisplatin and its clinically ineffective trans isomer. |
| Q40631549 | Early events in the induction of apoptosis in ovarian carcinoma cells by CD437: activation of the p38 MAP kinase signal pathway |
| Q39414094 | Euscaphic acid isolated from roots of Rosa rugosa inhibits LPS-induced inflammatory responses via TLR4-mediated NF-κB inactivation in RAW 264.7 macrophages |
| Q37535542 | Increased preventive effect on colon carcinogenesis by use of resistant starch (RS3) as the carrier for polysaccharide of Larimichthys crocea swimming bladder |
| Q33758201 | Involvement of the MEKK1 signaling pathway in the regulation of epicardial cell behavior by hyaluronan |
| Q40173444 | Kaposi's sarcoma-associated herpesvirus induces sustained NF-kappaB activation during de novo infection of primary human dermal microvascular endothelial cells that is essential for viral gene expression |
| Q40552652 | MEKK1 signaling through p38 leads to transcriptional inactivation of E47 and repression of skeletal myogenesis |
| Q45045445 | Negative regulation of hepatocellular carcinoma cell growth by signal regulatory protein alpha1. |
| Q43110174 | Nuclear Factor-kappa B as a Resistance Factor to Platinum-Based Antineoplasic Drugs |
| Q36085634 | Nuclear factor-kappaB inhibitors as sensitizers to anticancer drugs |
| Q39835063 | Over-expression of mitogen-activated protein kinase phosphatase-2 enhances adhesion molecule expression and protects against apoptosis in human endothelial cells |
| Q37714637 | Preventive Effect of Polysaccharide of Larimichthys crocea Swim Bladder on Reserpine Induced Gastric Ulcer in ICR Mice |
| Q85696582 | Preventive effects of the polysaccharide of Larimichthys crocea swim bladder on carbon tetrachloride (CCl4)-induced hepatic damage |
| Q28572424 | RhoA regulation of NF-kappaB activation is mediated by COX-2-dependent feedback inhibition of IKK in kidney epithelial cells |
| Q35177662 | Role of Jun and Jun kinase in resistance of cancer cells to therapy |
| Q39929809 | Role of glutathione S-transferase P1-1 in the cellular detoxification of cisplatin |
| Q39514532 | Roles of AKT1 and AKT2 in non-small cell lung cancer cell survival, growth, and migration |
| Q97905063 | Serum deprivation initiates adaptation and survival to oxidative stress in prostate cancer cells |
| Q37160973 | Shift from apoptotic to necrotic cell death during human papillomavirus-induced transformation of keratinocytes |
| Q36987488 | Signalling pathways involved in clinical responses to chemotherapy. |
| Q33803307 | Silencing of the JNK pathway maintains progesterone receptor activity in decidualizing human endometrial stromal cells exposed to oxidative stress signals |
| Q38306038 | Styraxoside A isolated from the stem bark of Styrax japonica inhibits lipopolysaccharide-induced expression of inducible nitric oxide synthase and cyclooxygenase-2 in RAW 264.7 cells by suppressing nuclear factor-kappa B activation |
| Q43133462 | TNF-alpha reduces the Na+/K+ ATPase activity in LLC-PK1 cells by activating caspases and JNK and inhibiting NF-kappaB. |
| Q40751673 | Targeting nuclear factor-kappa B to overcome resistance to chemotherapy. |
| Q42631227 | The role of calcium, NF-κB and NFAT in the regulation of CXCL8 and IL-6 expression in Jurkat T-cells |
| Q39470179 | Toll-like receptor 4 activates NF-κB and MAP kinase pathways to regulate expression of proinflammatory COX-2 in renal medullary collecting duct cells |
| Q37001622 | Transglutaminase 2 expression predicts progression free survival in non-small cell lung cancer patients treated with epidermal growth factor receptor tyrosine kinase inhibitor |
| Q24804943 | Two discrete events, human T-cell leukemia virus type I Tax oncoprotein expression and a separate stress stimulus, are required for induction of apoptosis in T-cells |
| Q42316245 | c-Jun-N-terminal phosphorylation regulates DNMT1 expression and genome wide methylation in gliomas |
Search more.